首页|期刊导航|时珍国医国药|四神丸对结肠炎小鼠结肠组织细胞能量代谢相关蛋白的调控作用

四神丸对结肠炎小鼠结肠组织细胞能量代谢相关蛋白的调控作用OA

Regulatory Effects of Sishen Pill(四神丸)on energy metabolism-related proteins in colonic tis-sues of mice with ulcerative colitis

中文摘要英文摘要

目的 明确四神丸对葡聚糖硫酸钠(DSS)诱导型结肠炎小鼠结肠组织细胞能量代谢相关蛋白的调节作用.方法 48只C57BL/6雄性小鼠随机分成四组,分别为正常组(Control)、正常+四神丸组(Control+SSP)、模型组(DSS)、模型+四神丸组(DSS+SSP).DSS组及DSS+SSP组采用2.5%DSS溶液复制结肠炎小鼠模型.实验第7日开始定时给予Control+SSP组与DSS+SSP组2.5 g·kg-1·d-1四神丸混悬液灌胃,其余两组给予相同容积的灭菌饮用水灌胃.密切观察各组小鼠体质量变化、粪便性状情况以及疾病活动指数(DAI),并测量各组小鼠结肠长度和脾脏质量等;HE染色后观察结肠组织病理损伤;ELISA检测结肠组织能量代谢ATP、ADP等相关核苷酸水平;qRT-PCR检测ATP酶相关基因的表达水平;WB测定结肠组织中Glut1、Glut2、Glut3、Glut4、AMPK-α1、PGC-1α和HIF-1α的表达水平.结果 DSS+SSP组较DSS组小鼠整体状态明显改善,体重在第17日显著升高(P<0.05/P<0.01),DAI评分自第11日起呈持续下降趋势(P<0.05/P<0.01);结肠长度有所恢复(P<0.01),脾重指数以及肠重指数明显下降(P<0.01);病理评分显著下降(P<0.01);结肠组织中的AMP、ADP、ATP水平及ATP比例明显下降(P<0.05),ADO 水平有所上升(P<0.05);ATP 酶相关基因(A T P 1 B 2、A T P 1 B 3、A T P 2 B 4、A T P 2 C 1、A T P 6 V、A T P 1 0 A、A T P 1 1 A、A T P 1 3 A 2、A T P 1 3 A 3)的mRNA水平不同程度升高(P<0.05/P<0.01),而Notch3、ATP5E、mTOR的mRNA水平有所下降(P<0.01);结肠组织中的Glut1、Glut2、Glut3、Glut4和HIF-1α蛋白水平显著降低(P<0.01),而AMPK-α1、PGC-1α的蛋白水平显著上升(P<0.01).结论 四神丸通过抑制HIF-1α/Glut轴减轻糖酵解亢进,同时激活AMPK/PGC-1α通路促进线粒体生物合成和ATP生成,逆转能量代谢紊乱以有效缓解DSS诱导型小鼠结肠炎.

Objective To clarify the regulatory effect of Sishen Pill(四神丸,SSP)on cell energy metabolism-related proteins in the colon tissue of mice with dextran sulfate sodium salt(DSS)-induced colitis.Methods Forty-eight male C57BL/6 mice were randomly divided into four groups:Control group,Control+SSP group,DSS model group,and DSS+SSP group.The colitis model was established using 2.5%DSS solution.From the 7th day of the experiment,mice in the Control+SSP and DSS+SSP groups were gavaged with 2.5 g·kg-1·d-1 of SSP aqueous extract,while the other two groups received the same volume of sterile drinking water.Changes in body weight,fecal traits,and Disease Activity Index(DAI)were closely monitored;colon length and spleen weight were measured.Pathological damage of colon tissue was observed after HE staining.ELISA was used to detect the levels of energy metabolism-related nucleotides(ATP,ADP,etc.)in colon tissue.qRT-PCR was performed to assess the mRNA expression levels of ATPase-related genes.WB was employed to determine the protein expression levels of Glut1,Glut2,Glut3,Glut4,AMPK-α1,PGC-1α,and HIF-1α in colon tissue.Results Compared with the DSS group,the overall condition of mice in the DSS+SSP group was significantly improved:body weight increased significantly on the 17th day(P<0.05/P<0.01);DAI score showed a continuous downward trend from the 11th day(P<0.05/P<0.01);colon length was restored(P<0.01);spleen weight index and intestinal weight index decreased significantly(P<0.01);pathological score was significantly reduced(P<0.01);levels of AMP,ADP,ATP,and ATP ratio in colon tissue decreased signifi-cantly(P<0.05),while ADO level increased(P<0.05);mRNA expression levels of ATPase-related genes(ATP1B2,ATP1B3,ATP2B4,ATP2C1,ATP6V,ATP10A,ATP11A,ATP13A2,ATP13A3)increased to varying degrees(P<0.05/P<0.01),whereas mRNA expression levels of Notch3,ATP5E,and mTOR decreased(P<0.01);protein expression levels of Glut1,Glut2,Glut3,Glut4,and HIF-1α in colon tissue were significantly reduced(P<0.01),while protein expression levels of AMPK-α1 and PGC-1α increased significantly(P<0.01).Conclusion SSP alleviates glycolysis hyperactivity by inhibiting the HIF-1α/Glut axis,and simulta-neously activates the AMPK/PGC-1α pathway to promote mitochondrial biogenesis and ATP production.It reverses energy metabolism disorder and effectively ameliorates DSS-induced colitis in mice.

周文;余飞浩;朱熙妍;刘雅真;俞济;赵海梅;刘端勇;陈文潇

江西中医药大学中医学院,江西 南昌 330004||南昌医学院,江西省卫生健康药效与安全性评价重点实验室,江西 南昌 330652广州中医药大学茂名医院,广东 茂名 525000江西中医药大学中医学院,江西 南昌 330004江西中医药大学中医学院,江西 南昌 330004江西中医药大学中医学院,江西 南昌 330004江西中医药大学中医学院,江西 南昌 330004江西中医药大学方证研究中心,江西 南昌 330004南昌医学院,江西省卫生健康药效与安全性评价重点实验室,江西 南昌 330652

医药卫生

四神丸溃疡性结肠炎HIF-1α/Glut信号AMPK/PGC-1α通路能量代谢

Sishen Pill(四神丸)Ulcerative colitisHIF-1α/Glut signalingAMPK/PGC-1α pathwayEnergy metabolism

《时珍国医国药》 2026 (8)

1414-1421,8

国家自然科学基金(82360871)江西省自然科学基金(20224BAB21611020252BAC240477)江西省卫生健康委员会科技计划(202211331)江西省教育厅科技技术研究项目(GJJ2403643GJJ2200965)

10.70976/j.1008-0805.SZGYGY-2026-0802

评论